New bacteriophage technologies are being developed to create rapid tests for bacterial infections.

by: Drew Smith

The ability to perform reliable, low-cost PCR amplification with either intercalating dyes or FRET probes will lead to an increased use of such a tool in clinical IVDs.

by: George Maltezos, Wasun Chantratita, Alvaro Gomez, Frank Gomez, Emil Kartalov, and Axel Scherer

As the two largest markets in Latin America with large populations and currently low per-capita spending on IVDs, the potential for growth in Brazil and Mexico is significant.

by: Carl McEvoy

An error grid, when augmented with a tally of nonreported results, accounts for 100% of data and separates errors into multiple severity-of-harm zones.

by: Jan S. Krouwer

 OIVD’s head of personalized medicine shares the agency’s current thinking on regulation of companion diagnostics.

by: Interview by Richard Park

   

by: Steven R. Binder

by: Richard Park

by: Maureen Kingsley

by: Maureen Kingsley

by: Richard Park